Bovie Medical, a maker of medical devices and supplies and the developer of J-Plasma, a patented new surgical product, announced that it has signed its first group purchasing organization (GPO) agreement with Amerinet for the use of J-Plasma by its members.

The 3-year agreement with Amerinet, one of the nation’s largest healthcare GPOs, is in effect now through September 2018.

Amerinet has more than 85,000 members, including 33,000 clinics, 3,500 acute care hospitals, and 3,300 ambulatory surgery centers.

Through this agreement, Amerinet members will have access to J-Plasma, Bovie’s transformational surgical product, which enables surgeons to operate with greater precision and minimal thermal spread.

"This agreement represents an important step in advancing the adoption of J-Plasma, and we are delighted to partner with Amerinet, which has an excellent reputation for providing its members with high quality healthcare products at reasonable costs," said Robert L. Gershon, Bovie’s Chief Executive Officer.

As a leading national healthcare solutions organization, Amerinet collaborates with acute and non-acute care providers to create and deliver unique supply chain solutions through performance improvement resources, guidance and ongoing support.

Bovie Medical is a leading maker of medical devices and supplies as well as the developer of J-Plasma, a patented new plasma-based surgical product for cutting and coagulation.

J-Plasma utilizes a helium ionization process to produce a stable, focused beam of ionized gas that provides surgeons with greater precision, minimal invasiveness and an absence of conductive currents through the patient during surgery.